BioSpace News Archive

Lone Star Bio

Nanoscope Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference

Nanoscope Therapeutics Inc. today announced that management will present at the Piper Sandler 34th Annual Healthcare Conference on Thursday, December 1, 2022, in New York.

November 22, 2022
·
1 min read
Genetown

Bicara Therapeutics to Present at 34th Annual Piper Sandler Healthcare Conference

Bicara Therapeutics today announced that Claire Mazumdar, PhD, MBA, Chief Executive Officer of Bicara Therapeutics, will present a corporate overview at the upcoming 34th Annual Piper Sandler Healthcare Conference, in New York, NY on Thursday, December 1, 2022 at 10:10 a.m. ET.

November 22, 2022
·
1 min read
Genetown

Ikena Oncology to Participate in the Piper Sandler 34th Annual Healthcare Conference

Ikena Oncology, Inc. today announced that management will present a corporate overview and participate in 1x1 investor meetings at the Piper Sandler 34th Annual Healthcare Conference, taking place November 29-December 1, 2022, in New York, NY.

November 22, 2022
·
3 min read
Biotech Beach

Kura Oncology to Participate in Two Upcoming Investor Conferences - November 22, 2022

Kura Oncology, Inc., announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in two upcoming investor conferences.

November 22, 2022
·
2 min read
Business

Vivos Therapeutics Provides Update on Revenue Recognition Review

Vivos Therapeutics, Inc today provided an update on its review of the Company’s revenue recognition policies and the expected timing for the release of its second and third quarter 2022 financial results.

November 22, 2022
·
7 min read
Bio NC

Top 10 Pharma Company Reduces Drug Wastage through Adoption of Calyx IRT Medication Pooling

Calyx announced that a Top 10 pharmaceutical company is leveraging medication pooling, an advanced inventory management strategy available through Calyx IRT, to improve drug distribution efficiencies and reduce drug wastage in an ongoing, global clinical development program.

November 22, 2022
·
2 min read
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - November 22, 2022

Avadel Pharmaceuticals plc announced today that members of management will participate in the following upcoming investor conferences.

November 22, 2022
·
1 min read
Achilles Therapeutics Announces Grant of US Patent on Immunotherapies Targeting Clonal Neoantigens Identified Using Proprietary Method

Achilles Therapeutics plc today announced that United States (US) patent 11,504,398 has been granted.

November 22, 2022
·
5 min read
Biotech Beach

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences - November 22, 2022

Ventyx Biosciences, Inc. today announced that Company executives will provide a company overview during fireside chats at the following upcoming investor conferences.

November 22, 2022
·
1 min read
Pharm Country

PMV Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference

PMV Pharmaceuticals, Inc. (Nasdaq: PMVP; “PMV Pharma”) today announced that David H. Mack, Ph.D., President & Chief Executive Officer of PMV Pharmaceuticals, will participate in a virtual fireside chat at the 5th Annual Evercore ISI HealthCONx Conference, taking place November 29 – December 1, 2022.

November 22, 2022
·
1 min read